LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 572 pages found matching <script>alert('What_Security?')</script>- More Studies Examine SSRI and Birth Defects
May-20-07 Seattle, WA: More studies are now underway to determine the link between certain types of antidepressants, known as selective serotonin reuptake inhibitors (SSRIs), and birth defects . Currently, The Yale Pink and Blue Study is being conducted to determine the association between depression, anti-depressant use during pregnancy, and the risk of del... - Abogado especializado en Seroquel en el juicio por efectos colaterales y diabetes
Seroquel se ha vinculado supuestamente con el aumento de los casos de diabetes y trastornos del nivel de azúcar en sangre, la hiperglucemia. Seroquel se utiliza como tratamiento para episodios maníacos agudos asociados con el trastorno bipolar I y el tratamiento de la esquizofrenia. Es un medicamento antipsicótico fabricado por As... - Credit Card Theft: An "Inside Job"
May-14-07 Ann Arbor, MI A Michigan State University study has shown that as much as 70 per cent of all identity theft -- including credit card theft -- is the work of "insiders" such as store clerks and other employees. Michigan State professor Judith Collins, director of an identity theft program at the university, randomly selected thousands of cases from aro... - Asbestos Lawsuits keep Rolling On
May-14-07 Redondo Beach, CA Ready for some more bad news about asbestos ? Apparently, asbestos poisoning is starting to strike people down at an earlier age. Why this is happening is unclear. "An increasing number of patients suffering from asbestos-related diseases are now younger than in previous reports," reads a May 9/2007 press release from the Asbestos Dis... - MGM Mirage Inc. Disability Act Violations Penalty
Biloxi, MS: (May-02-07) The Justice Department filed charges against MGM Mirage Inc., the world's second-largest casino company, following a complaint filed by a patron, alleging that fell in a shower because he couldn't reach shower controls. The suit claimed that the hotel had violated the Americans with Disabilities Act in making in designing their hote... - Protopic Warning Linked to Cancer
Apr-30-07 Washington, DC: Since January 2006, the skin ointment Protopic has been packaged with a boxed warning label intended to alert consumers that the product carries a cancer risk. This tough warning was added at the behest of the U.S. Food and Drug Administration (FDA), in response to several cancer cases among users of the drug. The only problem is, the... - E. Coli Outbreak From Fresh Bagged Spinach Total Passes 200.
The US Food and Drug Administration has issued an alert to consumers of fresh bagged spinach about an outbreak of E. coli O157:H7 in multiple states that may be associated with the consumption of produce. Preliminary epidemiological evidence suggests that bagged fresh spinach may be a possible source of this outbreak. Based on the current information,... - Asthma Medication could Stop You Cold
Apr-21-07 Washington, DC: Americans suffering from asthma may be worse off after taking the drug Xolair , according to a recent warning by the United States Food and Drug Administration. On February 21st 2007, the FDA recommended that Genentech Inc., the makers of Xolair, include a black box alert on the product packaging that warns of a severe, and potentially... - Zelnorm: The Benefits no longer Outweigh the Risks
Apr-20-07 East Hanover, NJ: The United States Food and Drug Administration (FDA) has announced that, at its request, Novartis Pharmaceuticals has stopped sales of Zelnorm . The action was taken after a study showed increased risk of serious side effects in people taking Zelnorm. The study, conducted by Novartis and submitted to the FDA, found that patients treat... - Government Agencies Warn Against Zoloft During Pregnancy
Apr-13-07 Washington, DC: If you want a healthy baby, government agencies in both Canada and the United States warn that you might want to quit taking Zoloft during pregnancy. Last year, the U.S. Food and Drug Administration and its Canadian counterpart, Health Canada, both issued warnings about combining Zoloft and pregnancy. "A recently published case-contro... - Black Box Warning Added To Epogen, Aranesp, and Procrit
Apr-12-07 Thousand Oaks, CA: A black box warning has been added to the labels of Epogen, Aranesp, and Procrit , a sign that the U.S. Food and Drug Administration (FDA) is concerned about the risks associated with using the anemia drugs. Doctors have also been warned that patients should be given the lowest possible dose in order to avoid blood transfusions. The... - FDA Finally Yanks Permax Off the US Market
Apr-6-07 Washington, DC: On March 29, 2007, the FDA withdrew Permax (pergolide) from the market because it increases the risk of valvular heart disease. Permax belongs to a class of drugs known as dopamine agonists that help regulate balance and movement in Parkinson's patients who suffer from a lack of dopamine. When Permax was FDA approved in 1988, Eli Lilly... - FDA Orders Changes to Ketek but Leaves It on the Market
Mar-26-07 Rockville, MD: The U.S. Food and Drug Administration (FDA) is making changes to the labeling of Ketek following pressure from numerous organizations regarding the drugs' safety. The organization has announced that Ketek will now come with a black box warning to alert consumers to the potential for serious side effects associated with taking the drug. ... - FDA Strengthens Warnings on Xolair
Mar-2-07 Seattle, WA: The U.S. Food and Drug Administration (FDA) has called for a black box warning label for Xolair after receiving reports of serious allergic reactions to the drug. The alert was given after the FDA learned of 48 instances of anaphylactic shock that occurred between June, 2003 and December, 2005. Xolair was approved by the FDA for use in 20... - Activists Take on Eli Lilly Over Off-Label Sale of Zyprexa
Feb-27-07 Washington, DC: On February 23, 2007, a new grass roots advocacy group issued a press release to rally support for attorney, Jim Gottstein, in his legal battle with Eli Lilly over his role in providing secret company documents obtained in litigation to the media to alert the public about the health risks associated with Zyprexa that were kept hidden si... - Suicide Risk of Neurontin Kept Hidden for Years
Feb-27-07 Washington, DC: Neurontin , the all-time poster child for an illegally promoted off-label drug, was marketed by Warner-Lambert and its Parke-Davis division until Pfizer acquired the company in 2000. The term "off-label" means prescribing a drug for indications not listed on the label, upping the recommended dose, prescribing a drug in combination with... - Zyprexa Injury Clock Keeps Ticking Away
Feb-2-07 San Jose, CA The on-going legal battle over the disclosure of secret Eli Lilly documents that reveal the serious health risks associated with Zyprexa and the company's off-label promotion of the drug involves a matter of grave public concern. But observers on the sidelines of this courtroom circus say the conduct of the judge in helping Lilly keep d... - No End in Sight for Fen-Phen Lawsuits
Jan-29-07 Rutherford, NJ: On December 5, 2006, five women with ages ranging from 53 to 71, who took the appetite suppressants drugs known as fen-phen in 1996 and 1997, filed lawsuits against Wyeth Pharmaceuticals after being diagnosed with a life-threatening lung disorder. These lawsuits demonstrate that the harm caused by fen-phen can surface many years after a... - Experts Predict Many Cases of Permax Heart Valve Damage
Jan-21-07 Washington, DC Nearly three years ago, HealthDay News reported that a study had confirmed previous findings that the drug, Permax , used to treat Parkinson's disease, could damage heart valves and surgery would be needed to correct the problem. The April 28, 2004, report quoted the lead researcher, Dr Richard Dewey Jr, an associate professor from the U... - Novartis failed to Warn about Elidel Cancer Link
Dec-28-06 Washington, DC: Most lawsuits in which drug makers have tried to use preemption to dismiss failure-to-warn claims have been against companies accused of failing to warn about the risk of suicide associated with antidepressants known as selective serotonin inhibitors or SSRIs. However, a case in Pennsylvania against Novartis, involves a toddler who devel...